An increasing number of pregnant women have received prescriptions for antipsychotics over the past few years, according to a recent study, which ultimately raises the question of whether Risperdal birth defects are likely and whether other similar medications may have adverse effects on unborn children.
Published in 2013 by the U.S. National Library of Medicine, National Institute of Health, the findings of a study indicate that the use of psychotropic medications in expectant mothers is on the rise. Among other conclusions, the 2013 study established a 2.5-fold increase in the number of antipsychotic prescriptions written for pregnant women for the purpose of treating depression, schizophrenia and bipolar disorder.
However, there is still the question of whether this practice is safe for the fetus. The Journal of Clinical Pscychopharmacology published a study in August 2013 that found that women taking Risperdal and other antipsychotics may be two times more likely to deliver a baby with birth defects such as cardiac malformations than those who did not take the drugs. Additionally, postnatal disorders were also more prevalent in children of mothers who took the drugs, according to scientists, who reported that heart defects are among the most common complications experienced by babies of antipsychotic-taking mothers.
Study Finds Risperdal Birth Defects in Babies Born to Risperdal Users
Three years prior, a study that specifically analyzed Risperdal’s effect on babies born to antipsychotic medication users also found negative side effects. Between 1998 and 2007, scientists at the University of Copenhagen collected data and found 429 cases of adverse events in children under the age of 17. More than half of these cases involved severe withdrawal symptoms and deformities.
Use of Risperdal, which is marketed by Janssen Pharmaceuticals and manufactured by its parent company, Johnson & Johnson, has been suggested in hundreds of Risperdal lawsuits to cause gynecomastia, or breast development in boys and young men. There are currently more than 500 pending Risperdal gynecomastia lawsuits underway in the Philadelphia Court of Common Pleas, alleinge that gynecomastia can result in a patient requiring a mastectomy or liposuction surgery to remove the excess breast tissue that might have developed due to Risperdal use.
Pursue a Risperdal Birth Defects Claim Today
To learn more about Risperdal birth defects or to determine whether you have a valid Risperdal gynecomastia lawsuit, contact Bernstein Liebhard LLP as soon as possible by filling out the case evaluation form on this page or by calling us at (855) 511-1001. If you or someone you love suffered from gyencomastia and you feel that the condition was directly caused by Risperdal, you may be entitled to recover damages for lost income, pain and suffering and medical expenses for any procedures necessary to treat the condition. The time to file is limited, so it is important to seek legal counsel as soon as possible to ensure that you have the best possible chance of pursuing a successful claim.